StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002584.SZ$7.43-2.24%
Fair $7.43+0.0%

002584.SZ

Xilong Scientific Co., Ltd.

Basic Materials / ChemicalsShenzhen

$7.43

-0.17 (-2.24%)

Fairly Valued+0.0%Fair Value $7.43Fund rank 23/100 · Data gapFallback financials|
SA 24/D
F-Score: 3/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-30.8M · quality 39.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 6/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

24/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -3.5%, below the 5% threshold
Thesis & Journal · 002584.SZLocal privado en este navegador · Xilong Scientific Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.3B

P/E

N/A

•

EV/EBITDA

88.5x

↑

ROE

-3.5%

↓

Gross Margin

7.1%

↓

Debt/Equity

0.59

↑
52-Week Range$7
$7$12

TradingView lightweight chart

002584.SZ price, volumen y niveles de valoración

Último $7.600Periodo +28.5%
Fair value: $7.430

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+5.8%

FCF CAGR

—

FCF margin

-0.4%

FCF / Net income

0.41x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $7.33B · net income $-75.5M · FCF $-30.8M

2022-FY → 2025-FY

Gross margin

7.1%-0.0% pts

Operating margin

2.3%+0.3% pts

Net margin

-1.0%-2.5% pts

FCF margin

-0.4%+7.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$7.33B$7.33B$7.82B$7.09B$6.18B
Net Income$-75.5M$-75.5M$61.8M$33.3M$89.1M
EBITDA$55.2M$55.2M$176.0M$153.1M$196.3M
EPS-0.13-0.130.110.060.15
Gross Margin7.1%7.1%6.9%6.6%7.1%
Operating Margin2.3%2.3%2.4%2.0%2.1%
Net Margin-1.0%-1.0%0.8%0.5%1.4%
Balance Sheet
Debt/Equity0.590.590.450.500.45
Current Ratio1.581.58———
Cash Flow
Free Cash Flow$-30.8M$-30.8M$257.2M$-500.0M$-514.6M
Returns
ROE-3.5%-3.5%2.7%1.4%3.9%
Valuation
P/E——64.91157.0045.73
EV/EBITDA88.5088.5025.3238.2222.57
P/B1.991.991.742.231.76
Growth & Yield
Revenue Growth-6.2%-6.2%10.2%14.7%—
EPS Growth-218.2%-218.2%83.3%-60.0%—
Dividend Yield0.6%0.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -25.1%

Total return

-25.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.11 → -0.13

Residual

-25.7%

EPS growthn/d
Multiple reratingn/d
Dividend+0.6%
Residual / FX / buybacks / cross-term-25.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.